Mechanism-based modeling of complex biomedical systems

被引:4
|
作者
Mosekilde, E
Sosnovtseva, OV
Holstein-Rathlou, NH
机构
[1] Tech Univ Denmark, Dept Phys, DK-2800 Lyngby, Denmark
[2] Univ Copenhagen, Dept Med Physiol, DK-2200 Copenhagen N, Denmark
关键词
D O I
10.1111/j.1742-7843.2005.pto960311.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Mechanism-based modeling is an approach in which the physiological, pathological and pharmacological processes of relevance to a given problem are represented as directly as possible. This approach allows us (i) to test whether assumed hypotheses are consistent with observed behaviour, (ii) to examine the sensitivity of a system to parameter variation, (iii) to learn about processes not directly amenable to experimentation, and (iv) to predict system behavior under conditions not previously experienced. The paper illustrates different aspects of the application of mechanism-based modeling through three different examples of relevance to the treatment of diabetes and hypertension: subcutaneous absorption of insulin, pulsatile insulin secretion in normal young persons, and synchronization of the pressure and flow regulation in neighbouring nephrons. The underlying ideas are that each regulatory mechanism represents the target for intervention and that the development of new and more effective drugs must be based on a deeper understanding of the biological processes.
引用
收藏
页码:212 / 224
页数:13
相关论文
共 50 条
  • [21] Modeling freeway incident response time: A mechanism-based approach
    Hou, Lin
    Lao, Yunteng
    Wang, Yinhai
    Zhang, Zuo
    Zhang, Yi
    Li, Zhiheng
    TRANSPORTATION RESEARCH PART C-EMERGING TECHNOLOGIES, 2013, 28 : 87 - 100
  • [22] Mechanism-based disease progression modeling for type 2 diabetes
    Jin, JY
    Abu-Raddad, EJ
    Prince, MJ
    Miller, AR
    Schiebinger, RJ
    DIABETES, 2004, 53 : A580 - A580
  • [23] Mechanism-based pharmacokinetic–pharmacodynamic modeling of antimicrobial drug effects
    David Czock
    Frieder Keller
    Journal of Pharmacokinetics and Pharmacodynamics, 2007, 34 : 727 - 751
  • [24] CASCADE PROCESS MODELING WITH MECHANISM-BASED HIERARCHICAL NEURAL NETWORKS
    Cong, Qiumei
    Yu, Wen
    Chai, Tianyou
    INTERNATIONAL JOURNAL OF NEURAL SYSTEMS, 2010, 20 (01) : 1 - 11
  • [25] A mechanism-based approach to modeling endocrine disruptor ligands.
    Hamme, A
    CHEMICAL RESEARCH IN TOXICOLOGY, 2004, 17 (12) : 1762 - 1763
  • [26] Modeling of the reaction mechanism of the decomposition of a new class of mechanism-based protease inhibitors
    Thondorf, I
    Brandt, W
    Stockel, A
    Demuth, HU
    PROTEIN AND PEPTIDE LETTERS, 1996, 3 (02): : 113 - 118
  • [27] Mechanism-Based Pharmacokinetic–Pharmacodynamic Modeling—A New Classification of Biomarkers
    Meindert Danhof
    Gunnar Alvan
    Svein G. Dahl
    Jochen Kuhlmann
    Gilles Paintaud
    Pharmaceutical Research, 2005, 22 : 1432 - 1437
  • [28] Mechanism-Based Energy Regularization in Computational Modeling of Quasibrittle Fracture
    Gorgogianni, Anna
    Elias, Jan
    Le, Jia-Liang
    JOURNAL OF APPLIED MECHANICS-TRANSACTIONS OF THE ASME, 2020, 87 (09):
  • [29] Mechanism-based pharmacokinetic-pharmacodynamic modeling: Biophase distribution, receptor theory, and dynamical systems analysis
    Danhof, Meindert
    de Jongh, Joost
    De lange, Elizabeth C. M.
    Della Pasqua, Oscar
    Ploeger, Bart A.
    Voskuyl, Rob A.
    ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2007, 47 : 357 - 400
  • [30] MECHANISM-BASED IMMUNOSUPPRESSANTS
    LULY, JR
    ANNUAL REPORTS IN MEDICINAL CHEMISTRY, 1991, 26 : 211 - 220